Tofacitinib Impurity 71 | CAS 1039738-27-6 - Request Quote
Tofacitinib Impurity 71
| SZ CAT No: | SZ-T010145 |
| CAS No | 1039738-27-6 |
| Mol.F. | C13H20N2 |
| Mol.Wt. | 204.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tofacitinib Impurity 71 is chemically 1-Benzyl-4-methylpiperidin-3-amine. Tofacitinib Impurity 71 is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Impurity 71 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1039738-27-6
Purchase 1039738-27-6
Order 1039738-27-6
Enquire 1039738-27-6
price of 1039738-27-6
1039738-27-6 Supplier
1039738-27-6 Manufacturer
1039738-27-6 Exporter
buy high quality Tofacitinib Impurity 71
Purchase Tofacitinib Impurity 71
Tofacitinib Impurity 71 suppliers
Tofacitinib Impurity 71 manufacturers
Tofacitinib Impurity 71 price
Order Tofacitinib Impurity 71
Enquire Tofacitinib Impurity 71
Tofacitinib Impurity 71 cost
Tofacitinib Impurity 71 Supplier
Tofacitinib Impurity 71 Distributor
Tofacitinib Impurity 71 for Method Validation
Tofacitinib Reference Standard
Tofacitinib Impurity 71 for ANDA Filing
Tofacitinib Impurity 71 for Forced Degradation Studies
Tofacitinib Impurity 71 Identification Standards
Tofacitinib Impurity 71 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


